Related Experiment Video

Updated: Jul 8, 2026

Measurement of Ion Concentration in the Unstirred Boundary Layer with Open Patch-Clamp Pipette: Implications in Control of Ion Channels by Fluid Flow
05:42

Measurement of Ion Concentration in the Unstirred Boundary Layer with Open Patch-Clamp Pipette: Implications in Control of Ion Channels by Fluid Flow

Published on: January 7, 2019

Open channel block of Kv3.1 currents by fluoxetine

Min Ji Sung1, Hye Sook Ahn, Sang June Hahn

  • 1Department of Pharmacology, Institute for Medical Sciences, Chonbuk National University Medical School, Jeonju, Chonbuk, Republic of Korea.

Journal of Pharmacological Sciences
|January 12, 2008
PubMed

Insights

Fluoxetine, a serotonin reuptake inhibitor, acts as an open-channel blocker for neuronal rat Kv3.1 channels. This action is concentration-dependent and affects channel inactivation and deactivation kinetics.

Area of Science:

  • Neuropharmacology
  • Ion Channel Physiology

Background:

  • Potassium channels, specifically Kv3.1, play critical roles in neuronal excitability.
  • Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are widely used antidepressants.
  • Understanding drug interactions with ion channels is crucial for predicting therapeutic and adverse effects.

Purpose of the Study:

  • To investigate the direct effects of fluoxetine on cloned neuronal rat Kv3.1 channels.
  • To characterize the mechanism and kinetics of fluoxetine's interaction with Kv3.1 channels.

Main Methods:

  • Whole-cell patch-clamp electrophysiology was employed.
  • Cloned rat Kv3.1 channels were stably expressed in Chinese hamster ovary cells.
  • Concentration-response, voltage-dependence, and kinetic analyses were performed.

Main Results:

  • Fluoxetine reversibly inhibited Kv3.1 currents in a concentration-dependent manner (IC50 = 13.4 μM).
  • Fluoxetine accelerated Kv3.1 current inactivation decay and slowed deactivation, acting as an open-channel blocker.
  • Inhibition was use-dependent and showed voltage dependence consistent with blocking open channels.

Conclusions:

  • Fluoxetine directly interacts with Kv3.1 channels, acting as an open-channel blocker.
  • The observed effects on channel kinetics suggest potential modulation of neuronal firing properties by fluoxetine.
  • This interaction may contribute to the overall neurophysiological effects of fluoxetine beyond serotonin reuptake inhibition.

More Related Videos

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...